Skip to content

FINHUB Insights

EN

Sign in Sign up

Colgate-Palmolive

CL Consumer Staples Market cap $70.1B as of Sep 14, 2026 16:00 ET S&P 500

Q2 FY26 Apr 1 – Jun 30, 2026 reported Jul 31, 2026

Revenue$5.36B +5% year over year

Gross profit$3.30B 61% margin

Operating profit$1.02B 19% margin

Net profit$0.69B 13% margin

The numbers behind the diagram

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 30, 2026).
Item	Value	Share of revenue	Year over year
Revenue	5.36	100%	+5%
Oral personal & home care	4.17	78%	+5%
Hills pet nutrition	1.20	22%
Cost of revenue	−2.07	39%
Gross profit	3.30	61% margin	+1pp
SG&A	−2.13	40%	+1pp
Other	−0.15	3%
Operating profit	1.02	19% margin	−2pp
Interest & other costs	−0.09
Tax	−0.23
Net profit	0.69	13% margin	−2pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
Item	Value	Share of revenue	Year over year
Revenue	5.32	100%	+8%
Oral personal & home care	4.13	78%	+9%
Hills pet nutrition	1.19	22%	+7%
Cost of revenue	−2.10	39%
Gross profit	3.23	61% margin	+0pp
SG&A	−2.08	39%	+0pp
Other	−0.19	3%	+0pp
Operating profit	0.96	18% margin	−4pp
Interest & other costs	−0.11
Tax	−0.21
Net profit	0.65	12% margin	−2pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Dec 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	5.23	100%	+6%
Oral personal & home care	4.03	77%	+6%
Pet nutrition	1.20	23%	+5%
Cost of revenue	−2.08	40%
Gross profit	3.15	60% margin	+0pp
SG&A	−2.07	39%	+1pp
Other	−0.98	19%	+0pp
Operating profit	0.09	2% margin	−20pp
Tax	−0.13
Net profit	−0.04	−1% margin	−16pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	5.13	100%	+2%
Oral personal & home care	3.99	78%	+2%
Pet nutrition	1.14	22%	+1%
Cost of revenue	−2.08	41%
Gross profit	3.05	59% margin	−2pp
SG&A	−1.97	39%	−1pp
Other	−0.02	0%	+0pp
Operating profit	1.06	21% margin	−1pp
Interest & other costs	−0.10
Tax	−0.23
Net profit	0.74	14% margin	+0pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	5.11	100%	+1%
Oral personal & home care	3.95	77%	+0%
Pet nutrition	1.16	23%	+4%
Cost of revenue	−2.04	40%
Gross profit	3.07	60% margin	−1pp
SG&A	−1.96	38%	+0pp
Other	−0.03	1%	+0pp
Operating profit	1.08	21% margin	+0pp
Interest & other costs	−0.10
Tax	−0.23
Net profit	0.74	15% margin	+0pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

Financial health

The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.

The balance sheet, capital flow, debt schedule and capital structure open with a free account.

Quarter by quarter

Every set of results we hold, newest first. Open one on its own page.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q2 FY26 Apr 1 – Jun 30, 2026 reported Jul 31, 2026 Operating margin 19% Net profit $0.69B	Apr 1 – Jun 30, 2026	Jul 31, 2026	$5.36B	+5%	19%	$0.69B	13%
Q1 FY26 Jan 1 – Mar 31, 2026 reported May 1, 2026 Operating margin 18% Net profit $0.65B	Jan 1 – Mar 31, 2026	May 1, 2026	$5.32B	+8%	18%	$0.65B	12%
Q4 FY25 Oct 1 – Dec 31, 2025 reported Feb 23, 2026 Operating margin 2% Net profit −$0.04B	Oct 1 – Dec 31, 2025	Feb 23, 2026	$5.23B	+6%	2%	−$0.04B	−1%
Q3 FY25 Jul 1 – Sep 30, 2025 reported Oct 31, 2025 Operating margin 21% Net profit $0.74B	Jul 1 – Sep 30, 2025	Oct 31, 2025	$5.13B	+2%	21%	$0.74B	14%
Q2 FY25 Apr 1 – Jun 30, 2025 reported Aug 1, 2025 Operating margin 21% Net profit $0.74B	Apr 1 – Jun 30, 2025	Aug 1, 2025	$5.11B	+1%	21%	$0.74B	15%